Detalles de la búsqueda
1.
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions.
Cancer Sci
; 112(8): 3029-3040, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34058788
2.
Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth.
Haematologica
; 102(2): 381-390, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27658435
3.
Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth
Haematologica
; 106(9): 2507-2510, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33882638
4.
Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study.
Haematologica
; 100(4): 541-7, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25682600
5.
Impact of interleukin-6 in hematological malignancies.
Transfus Med Hemother
; 40(5): 336-43, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24273487
6.
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
Front Immunol
; 14: 1178817, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37346044
7.
Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab.
Front Immunol
; 13: 949140, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36052078
8.
The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation.
Int J Cancer
; 126(1): 239-46, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19621390
9.
Striking a balance between national interests and patients' needs: cross-border projects meeting European challenges.
World Hosp Health Serv
; 46(4): 4-6, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21391444
10.
Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo.
Mol Cancer Ther
; 8(1): 26-35, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19139110
11.
Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.
Cancer Res
; 67(4): 1783-92, 2007 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17308121
12.
Retraction: Mechanisms by which SGN-40, a Humanized Anti-CD40 Antibody, Induces Cytotoxicity in Human Multiple Myeloma Cells: Clinical Implications.
Cancer Res
; 84(6): 936, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486489
13.
Retraction: Insulin-like Growth Factor-1 Induces Adhesion and Migration in Human Multiple Myeloma Cells via Activation of ß1-Integrin and Phosphatidylinositol 3'-Kinase/AKT Signaling.
Cancer Res
; 84(6): 938, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486484
14.
STAT3-induced long noncoding RNAs in multiple myeloma cells display different properties in cancer.
Sci Rep
; 7(1): 7976, 2017 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28801664
15.
A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries.
Oncotarget
; 8(44): 77552-77566, 2017 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29100408
16.
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Clin Cancer Res
; 11(11): 4251-8, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15930364
17.
Proteasomal degradation of topoisomerase I is preceded by c-Jun NH2-terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myeloma.
Cancer Res
; 64(23): 8746-53, 2004 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15574786
18.
Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implications.
Cancer Res
; 64(8): 2846-52, 2004 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15087402
19.
Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signaling.
Cancer Res
; 63(18): 5850-8, 2003 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14522909
20.
The novel multispecies Fc-specific Pseudomonas exotoxin A fusion protein α-Fc-ETA' enables screening of antibodies for immunotoxin development.
J Immunol Methods
; 418: 75-83, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25701195